Modern Rheumatology

Papers
(The H4-Index of Modern Rheumatology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Comparison between the BioPlex 2200 ANA Screen™ and a conventional method with respect to the detection of autoantibodies91
The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid ar39
Characteristics of patients presenting with concomitant carpal tunnel syndrome at the initial diagnosis with rheumatoid arthritis30
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort27
Correction to: Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study27
The effectiveness and safety of subcutaneous methotrexate injection in Japanese patients with rheumatoid arthritis in a real-world setting27
Consideration of useful patient-reported outcome measures to identify the unmet medical needs of children and adults with autoimmune and autoinflammatory diseases26
The dietary acid load is associated with disease severity in psoriatic arthritis25
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS study23
Expert perspectives on pathological findings in vasculitis23
The trends in the prevalence of arthritis and arthralgia and their associations with extra-articular manifestations in patients with Behcet’s disease: A systematic review and meta-analysis22
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review21
IL-18 receptor-α signalling pathway contributes to autoantibody-induced arthritis via neutrophil recruitment and mast cell activation21
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease19
1 mg/day or 10 mg/week? Folic acid supplementation with methotrexate in rheumatoid arthritis17
Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis17
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance17
0.073513984680176